They may for their own accounts also buy, sell, or hold long or short positions in any of the other securities mentioned in this report.

[Benny <nfqx@xxxxxxxxxxxxx>]

ERMX Grabs Edge Of US Trade With China And Moves Into Nitride Devices!

EntreMetrix Inc. (ERMX)
$0.16

Congress's push to increase trade agreements with China gives ERMX huge
advantage as they enter joint venture to manufacture Nitride Devices for
military, energy and technological solutions in China. This is huge. Get
on ERMX Monday!

Nothing herein should be construed as an offer to buy or sell securities
or to give individual investment advice. At the end of the day, you
should be right more often than wrong with the sectors you  select.
News from clinical trials can make or break a company's share price.
All too often, investors exclusively use broadly diversified, no load
mutual funds for their stock investments.

Finance   Companies for their part are also aggressive in reducing
cycle-time. You must also be able to make informed decisions on sectors
to select and sectors to avoid. Nothing herein should be construed as an
offer to buy or sell securities or to give individual investment advice.
Exchange traded sector funds such as Select  Sector SPDRs, iShares, and
Sector HOLDRS, that trade on the American Stock Exchange, can also be
used to construct diversified sector fund portfolios.
AlphaProfit Investments, LLC disclaims any liability for any direct or
incidental  loss incurred by applying any of the information in this
article. News from clinical trials can make or break a company's share
price. Take a proactive approach to sector investing through sector
rotation.

-based supermarket chain. AlphaProfit Investments, LLC does not
represent that this information, including any third party information,
is accurate or complete and it should not be relied  upon as such.

While biotechnology firms seek to merge among themselves, pharmaceutical
companies are also targeting biotechnology companies.
Genentech, for example, was ready to launch Avastin literally within
hours of getting FDA approval.

The newsletter's model portfolios have delivered powerful results
through prescient sector rotation. Please review our terms and
conditions, which govern your use of this newsletter.

While bottoms are hard to pick, there is a case to be made for going
long with this sector.
The answer depends on the company and how strong the moat is. In a
related article, we have looked at how investors can use sector funds 
to construct a diversified, no load mutual fund portfolio. Once
considered sleepy, steady companies, supermarket chains have proven to
be far from safe given their current competitive environment.

It is generally not advisable to commit a substantial portion of your
total assets to a single sector fund. No part of this document may  be
reproduced in any manner without written permission of AlphaProfit
Investments, LLC.

The information contained in this report is obtained from various
sources believed to be accurate and is provided without warranties of
any kind. A Caveat Diversification is one of the cornerstone principles
of mutual fund investing.

For example, until not too long ago, major corporations pruned
technology related capital spending whereas falling  interest rates kept
consumer spending strong.
To better communicate  our sector fund selection process, we have added
an illustration  to the AlphaProfit Investment  Approach web page.

News from clinical trials can make or break a company's share price.
News from clinical trials can make or break a company's share price.

Some of the development stage companies have appeal as takeover
candidates whereas the industry leaders in the HOLDRS are more likely to
be buyers than sellers.

A notable absentee in IBB is Genentech, whose shares trade on the NYSE.
Stocks, bonds, and cash typically form the  major asset classes for
constructing portfolios of no load mutual funds. Between the two
available ETFs, the iShares fund offers better diversification and has
higher exposure to development-stage companies. The  Motley Fool, Inc.